Drug Search Results
More Filters [+]

Desonide

Alternative Names: desonide, locapred, desowen, verdeso, desonate, desrx, tridesilon cream, tridesilon
Latest Update: 2024-03-14
Latest Update Note: News Article

Product Description

Desonide is used to treat the redness, swelling, itching, and discomfort of various skin conditions, including psoriasis (a skin disease in which red, scaly patches form on some areas of the body and eczema (a skin disease that causes the skin to be dry and itchy and to sometimes develop red, scaly rashes). Desonide is in a class of medications called topical corticosteroids. It works by activating natural substances in the skin to reduce swelling, redness, and itching. (Sourced from: https://medlineplus.gov/druginfo/meds/a605025.html)

Mechanisms of Action: Corticosteroid Hormone Receptor Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Topical

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Australia | Bangladesh | Brazil | Bulgaria | Canada | Chile | Colombia | Dominican Republic | Ecuador | Egypt | Finland | France | Hong Kong | India | Indonesia | Ireland | Italy | Korea | Lebanon | Malaysia | Mexico | Morocco | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Russia | Singapore | South Africa | Sri Lanka | Sweden | Tunisia | Turkey | United States | Uruguay | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Minsheng Pharmaceutical
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Desonide

Countries in Clinic: China

Active Clinical Trial Count: 2

Highest Development Phases

Phase 1: Dermatitis|Inflammation

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CTR20210696

P1

Not yet recruiting

Inflammation|Dermatitis

None

CTR20212217

P1

Not yet recruiting

Inflammation|Dermatitis

None

Recent News Events